there is no anti-malnutrition pill!
TRANSCRIPT
2/20/2017
1
Optimization of Nutrient Intake in Hospitalized Adult Patients
Melanie Horbal Shuster, PhD, CRNP Allegheny Health Network Center for Digestive Health-Medical Nutrition Pittsburgh, PA
There is no anti-malnutrition pill!
2
Objectives: 1. List physical findings necessary to diagnosis malnutrition
2. Identify and describe nutritional and pharmacologic interventions to
prevent and treat malnutrition in the hospitalized adult patient.
3. List indications and rationale for the use of nutritional and pharmacologic interventions to prevent and treat malnutrition in the hospitalized adult patient.
4. Describe prescriptive and evaluative parameters for nutritional therapies.
5. Correctly prescribe pharmacological agents to treat malnutrition.
3
2/20/2017
2
Mal
nu
trit
ion
Mo
del
fo
r C
NS
Pra
ctic
e
4
Malnutrition: Definition Occurs when nutritional intake does not provide
adequate calories, protein, and other nutrients for tissue maintenance, function, and growth, or nutrients are not fully utilized due to illness.
No nutrition intervention Average well nourished patient on admission
Nutrition intervention
Malnourished on admission
Length of stay > 5-7 days
5
Nursing Nutrition Responsibilities
Identifying the signs and symptoms of malnutrition
Assisting with oral intake
Administering medications to decrease the GI symptoms
Administering nutritional therapy Enteral nutrition
Parenteral nutrition
Monitoring for side effects and complications
Monitoring the effectiveness of nutritional interventions
6
2/20/2017
3
CNS Nutrition Goals During Hospitalization
Promote nutrition
Prevent malnutrition
Treat malnutrition
7
CNS Nutrition Goals During Hospitalization
Promote nutrition by: Assessing for adequate intake
Prescribing oral nutritional supplements
Prevent malnutrition by: Limiting NPO status
Advance the diet as soon as possible
Prescribe appropriate medications for GI symptoms,
nutritional supplements,
enteral nutrition including tube feedings or
parenteral nutrition
8
CNS Nutrition Goals During Hospitalization
Treat malnutrition by: Prescribing Medications
Nutritional supplements
Enteral access device for enteral feedings
Vascular access device for parenteral nutrition
9
2/20/2017
4
Nutrition Management
Interprofessional Collaboration
Interprofessional Team:
Nurses
Dieticians
Pharmacists
Physicians/Advanced Practice Providers
Others: PCTs, diet technicians 1
10
Overview I. Oral Nutritional
Supplements (ONS)
Nutrient enhancement Protein
Energy
Meal replacement
Vitamins
Minerals
II. Adjuncts
(Appetite stimulants) Anti-depressants
Appetite stimulants
Endocrine
11
Overview III. Gastrointestinal Agents
Motility agents Prokinetics
Anti-diarrheals
Narcotics
Secretory inhibitors Histamine blockers
Proton pump inhibitors
Hormone therapy
Pancreatic enzymes
Antibiotics
Bile acid binders
IV. Invasive Nutritional Support
Enteral therapy
(Tube feedings)
Parenteral therapy
(PPN-TPN)
12
2/20/2017
5
I. Oral Nutrition Supplements When to administer
Meal replacement
Between meals
Vitamins Thiamine
B12
Vitamin D5
Minerals Iron
Calcium
13
II. Adjuncts Drug Categories
Antihistamine
Anti-emetics
Antidepressants Mertazapine 15 mg tablets Q HS
Synthetic Hormones Appetite stimulants Dronabinol 2.5 mg BID
Megestrol 625 mg Q day
Glucocorticoid treatment
14
III. Gastrointestinal Agents Gastrointestinal symptoms often affect nutrient intake
Examples:
Nausea
metoclopramide 5 mg TID
ondansetron 4-8 mg every 8 hours
Diarrhea
Shorten intestine
Maldigestion
Malabsorption
15
2/20/2017
6
II. Adjuncts Synthetic Hormones Growth Hormone
Cachexia HIV associated 0.1 mg/kg SC Q HS
Oxandrolone 2.5 -20 mg PO BID-QID maximum dose 20 mg/day – 10mg BID Elderly 5 mg BID
Testosterone Transdermal patch 2-4 mg /24 hours Topical 2% 30mg/1.5 mL pump Measure serum testosterone Begin 2 mg or 1 pump daily
16
III. Gastrointestinal Agents Drug Categories
Motility agents Anti-diarrheals
Narcotics
Secretory inhibitors Histamine blockers
Proton pump inhibitors
Hormone therapy
Pancreatic enzymes
Antibiotics
17
III. Gastrointestinal Agents
Motility Agents Secretory Inhibitors
Anti-diarrheals
Loperamide
2 mg BID-QID
Diphenoxylate-atropine
1-2 tablets BID-QID
Narcotics
Codeine sulfate
15-30 mg BID-QID
Histamine blockers Ranitidine
20-40 mg PO QD-BID
Proton pump inhibitors Insurance driven
Hospital formulary
Hormone therapy Octreotide
50 mcg SQ TID
18
2/20/2017
7
III. Gastrointestinal Agents Pancreo-Biliary Agents Antibiotics Bile acid binders: Cholestyramine
1 gm q day or BID increase to maximum dose of 4 gms QID
Pancreatic enzymes administer with meals Pancrelipase
Lipase/protease/amylase 6K/19K/30K to 36K/114K/180K
Lipase/protease/amylase 4.2K/10K/17.5K to 21K/37K/61K
Lipase/protease/amylase 10.44K/39.15K/39.15K to 20.88K/78.3K/78.3K
Rotational oral antibiotics
Cephalexin
250-500 mg PO BID
Metronidazole
250 mg PO BID
Ciprofloxacin
250 mg PO BID
Doxycycline
100 mg PO BID
Trimethoprim/ sulfamethoxazole
80/400 mg 1 PO BID
19
IV. Artificial and Invasive Nutritional Support
Enteral Therapy (tube feedings)
Requires placement of an enteral access device
Nasoenteric
Gastric
Jejunal
Parenteral therapy (PPN-TPN)
Requires placement of vascular access device
Peripheral
Midline
Central
20
IV. Artificial and Invasive Nutrition Support Enteral Feeding Product selection
Nutritional needs GI function
Administration schedule Bolus: 2 cans QID Intermittent: 100 ml/hr x 12
hours Q HS Continuous: 83 ml/hr x 24
hours
Prescribe water flushes Tube patency Hydration needs Intake and Output
21
2/20/2017
8
IV. Artificial and Invasive Nutrition Support
Parenteral Feeding
Partial or peripheral Parenteral Nutrition (PPN)
Larger volume
Osmolality 600-800
Total or central Parenteral Nutrition (TPN)
Volume varies
Continuous
Night cycle
22
IV. Artificial and Invasive Nutrition Support Enteral Feeding Parenteral Feeding Product selection
Nutritional needs GI function
Administration schedule Bolus: 2 cans QID Intermittent: 100 ml/hr x 12
hours Q HS Continuous: 83 ml/hr x 24
hours
Prescribe water flushes Tube patency Hydration needs Intake and Output
Partial or peripheral Parenteral Nutrition (PPN)
Larger volume
Osmolality 600-800
Total or central Parenteral Nutrition (TPN)
Volume varies
Continuous
Night cycle
23
Ordering Parenteral Nutrition Determine weight8
Ideal
Actual
Adjusted
Determine energy needs Example 30 kcal/day X 70kg= 2100 Kcal/day
Determine hydration needs: Example: 30 ml/kg X 70 kg= 2100 ml/day
Determine protein needs Example 1.5 grams/Kg/day = 105 grams/day
24
2/20/2017
9
Ordering Parenteral Nutrition Example
70 kg patient
Total calorie @ 30/Kg/day = 2100 kcal
Water needs @ 30 ml/Kg/day =2100 ml
Protein @ 1.5 grams/Kg/day = 105 grams
25
Ordering Parenteral Nutrition Energy = 2100 Kcalories Protein = 105 grams/day
Protein = 4 Kcalories/g
Dextrose = 3.4 Kcalories/g
Fat = 9 Kcalories/g
Fat emulsion
Soybean oil
Egg phospholipid
Glycerol
10% = 1.1 Kcalories/ml
20% = 2 Kcalories/ml
30% = 3 Kcalories/ml
Calculate the energy from protein 105 x 4 = 420 Kcalories
Subtract protein calories from total calories 2100-420 = 1680
1680 Kcalories to be provided from carbohydrate and fats
60% as Carbohydrate 1680 x 0.6 = 1008/3.4 = 297 g
40 % as Fat 1680 x 0.4 = 672/9 = 59 g
26
Electrolytes Sodium- 1-2 meq/kg/d (For the example 70-140
meq/day)
Potasium-1-2 meq/kg/day (For example 70-140 meq/day)
Magnesium-16 meq/day
Calcium Gluconate-10 meq/day
Phosphorous- 30 mmol/day (as Na phosphate or K phosphate)
27
2/20/2017
10
Additional Additives To Consider Based on the situation, most patients may require:
Multivitamins- 10 ml/day
Trace elements- 1 ml/day
Insulin
Start with an initial dose of 0.1 to 0.2 unit/gram of dextrose
Thiamine-100 mg /day for 3 days if the patient has been without eating for > 1 week and or if vomiting.
Famotidine-20-40 mg/day
28
Patient Evaluation Monitor:
Daily oral intake
Daily intake and output
Baseline data C - reactive protein (CRP)
Pre-albumin
Liver function tests
CMP
Magnesium
Phosphorus
Ionized calcium
HA1c
POC glucoses every 6 hours
Serum triglycerides the morning after to first dose of TPN with lipid emulsion
Daily laboratory results
Weekly weights
29
References: 1. National CNS Competency Task Force. 2010. Clinical nurse specialist core competencies. Executive Summary 2006-2008. 2. The Academy of Nutrition and Dietetics. (2015). Retrieved from http://sc.eatrightpro.org/uncategorized/malnutrition-
resource-center. 3. Malone, A, Hamilton, C. (2013). The Academy of Nutrition and Dietetics/The American Society for Parenteral and Enteral
Nutrition [ASPEN] consensus malnutrition characteristics: Application in practice. Nutrition clinical practice, 28(6), 639-650. 4. Hamilton, C. & Boyce, V. (2013). Addressing malnutrition in hospitalized adults. Journal of parenteral and enteral nutrition, 37
(6), 808-813. 5. National Guideline Clearinghouse (NGC). Guideline summary: Evaluation, treatment, and prevention of vitamin D deficiency:
an Endocrine Society clinical practice guideline. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2011 Jul 01. [cited 2016 Dec 15]. Available: https://www.guideline.gov
6. Lochs, H, Dejong, C, Hammarqvist, F, Hebuterne, X, Leon-Sanz, M, Schutz, T, van Gemert, W, van Gossum, A, Valentini, L, Lu, H, Bischoff, S, Engelmann, N, Thul, P. (2006). Clinical Nutrition, 25, 260-274. Guidelines on Enteral Nutrition: Gastroenterology http://espen.info/documents/ENGastro.pdf
7. Matarese, LE, O’Keefe, SJ, Kandil, HM, Bond F, Costa, G, Abu-Elmagd,K. (2005). Short Bowel Syndrome: Clinical Guidelines for Nutrition Management. Nutrition Clinical Practice, 20 (5), 493-502.
8. National Guideline Clearinghouse (NGC). Guideline summary: A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Nov 01. [cited 2016 Dec 15]. Available: https://www.guideline.gov
9. Bozzetti, F. Forbes, A. (2009). ESPEN Guidelines on Parenteral Nutrition. Clinical Nutrition, 24 (4), 359-364.
30